ZEMBRACE SYMTOUCH is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Upsher-smith Laboratories, Llc. The primary component is Sumatriptan Succinate.
Product ID | 0245-0809_244d4062-dd68-4e48-bf3b-dffa347d25ea |
NDC | 0245-0809 |
Product Type | Human Prescription Drug |
Proprietary Name | ZEMBRACE SYMTOUCH |
Generic Name | Sumatriptan Succinate |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2016-02-22 |
Marketing Category | NDA / NDA |
Application Number | NDA208223 |
Labeler Name | Upsher-Smith laboratories, LLC |
Substance Name | SUMATRIPTAN SUCCINATE |
Active Ingredient Strength | 3 mg/1 |
Pharm Classes | Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC],Serotonin 1b Receptor Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2021-01-04 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0245-0809 | ZEMBRACE SYMTOUCH | Sumatriptan Succinate |
67857-809 | ZEMBRACE SymTouch | ZEMBRACE SymTouch |
0173-0449 | IMITREX | sumatriptan succinate |
0173-0478 | IMITREX | sumatriptan succinate |
0173-0479 | IMITREX | sumatriptan succinate |
0173-0735 | IMITREX | sumatriptan succinate |
0173-0736 | IMITREX | sumatriptan succinate |
0173-0737 | IMITREX | sumatriptan succinate |
0173-0739 | IMITREX | sumatriptan succinate |
0093-2013 | Sumatriptan | sumatriptan succinate |
0093-2014 | Sumatriptan | sumatriptan succinate |
0378-5630 | Sumatriptan Succinate | sumatriptan succinate |
0378-5631 | Sumatriptan Succinate | sumatriptan succinate |
0378-5632 | Sumatriptan Succinate | sumatriptan succinate |
0703-7351 | Sumatriptan Succinate | Sumatriptan Succinate |
0781-3169 | SUMATRIPTAN SUCCINATE | sumatriptan succinate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ZEMBRACE SYMTOUCH 87150791 5478282 Live/Registered |
UPSHER-SMITH LABORATORIES, LLC 2016-08-25 |